跳至主要内容
临床试验/CTRI/2011/08/001950
CTRI/2011/08/001950已完成不适用

A prospective, observational, multicenter study comparing Tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI

STEMI India Charitable Trust7 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年2月9日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
7
主要终点
Following are the Primary Endpoints:

研究概览

简要总结

This is a study comparing 2 treatment options that are available and practiced for the treatment for STEMI.  There will be no treatment assigned for the study and no intervention done for the study . Data will be collected on an observational basis from patients who undergo primary PCI and from patients who receive facilitated PCI for the same condition**.**xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /

Primary objective:

The primary objective of this study is to assess theefficacy of prompt fibrinolysis coupled with contemporary antiplatelet and antithrombotic therapy at first medical contact followed by timely catheterization or rescue coronary intervention in STEMI patients within 12 hours of symptom onset versus a strategy of Standard Primary Percutaneous Coronary I

Study hypothesis:

Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction is a preferred mode of revascularization as compared to thrombolytic therapy.  There is no primary data on Primary Percutaneous Coronary Intervention Vs TNK facilitated Percutaneous Coronary Intervention. In Indian context TNK facilitated PCI (Pharmacoinvasive therapy) is a more practical solution.  This study aims to confirm the efficacy and safety of Primary PCI Vs Pharmacoinvasive therapy in 200 patients across 8 centers.

Serious Adverse Events:

Centre Name: Kovai medical Centre,Coimbatore

Principal Investigator: Dr.Thomas Alexender

SAE reported : Cardiogenic shock

SAE reported on : 02 -Oct-2011

SAE out come : Death

Causal relation with treatment : not applicable

SAE narrative:

60 years old patient was admitted with compliance of chest pain ,breathlessness on 29-O9-2011, ECG was performed and the result  showed ST elevation .

Patient was considered for the study and hence screened. Preangioplasty angiogram revealed total occlution of the LAD proxiamlly which was Stented with drug eluting stent .During the procedure patient had bradycardia and bundle branch block for which the patient was put on temporary pacing and Ionotropic support.Patient was intubated and ventilatedfor persistent and worsening hypoxemia.patient was having persistant hypotension and requring multiple inotropic support. on 02-10-2011 at 9:15 am patient had asystolic cardiac arrest .CPR started as per the ACLS protocol .Inspite of all resuscitative efforts patient could not be revieved and declared death at 09:27 am on 02-10-2011

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • All patients included in the study should satisfy the following criteria.
  • 1.Adults 18 to 75 years of age complaining of chest pain, discomfort and/or indications of STEMI requiring either primary PCI or tenecteplase facilitated PCI will be included in the study.
  • 2.Patients presenting with the onset of symptoms within 12 hours.
  • 3.ECG including right ventricular leads (V4R) indicative of an acute STEMI (ST elevation will be measured from the J point scale; 1 mm per 0.1 mV greater than or equal to 2 mm ST elevation across 2 contiguous precordial leads (V1-V6) or leads I and aVL for a minimum combined total of greater than or equal to 4 mm ST elevation) OR Greater than or equal to 3mm ST elevation in 2 contiguous inferior leads (II, III, aVF) for a minimum combined total of greater than or equal to 6 mm ST elevation.
  • 4.Subjects / LAR or impartial witness (if applicable) must be able to understand and provide their consent in the informed consent form.

排除标准

  • Patients meeting any of the following criteria will not be enrolled into the study.
  • 1.Previous enrollment in this study or treatment with the investigational drug or participating in any other study in the past 30 days 2.Patients who are unwilling to participate in the study or sign the informed consent.

结局指标

主要结局

Following are the Primary Endpoints:

时间窗: Nil

Death and reinfarction

时间窗: Nil

Death due to cardio vascular reasons may include:

时间窗: Nil

1)Reinfarction

时间窗: Nil

Death maybe due to cardio vascular and non-cardio vascular reasons.

时间窗: Nil

2)Cardiogenic Shock

时间窗: Nil

3)Cardiac failure

时间窗: Nil

2)Others

时间窗: Nil

Death due to non cardio vascular reasons may include

时间窗: Nil

1)Procedure related injury

时间窗: Nil

次要结局

  • Following are the Secondary Endpoints:(1)Nonintracranial hemorrhage (total, major, minor and blood transfusions))

研究者

发起方
STEMI India Charitable Trust
申办方类型
Other [Investigator initiated study]

研究点 (7)

Loading locations...

相似试验